CEO Ralf Schmidt raised another 15 million NOK in new capital and now he is asked to present Biovotec to the British health authorities.

 

 

Please reload

Media Contact:     +47 95 94 99 78

Recent Posts
Please reload

Archive
Please reload

Engebrets vei 3, 0275 Oslo, Norway                                                   © Biovotec AS                                                                       info@biovotec